Home Briefing Developers Pricing

Search live market data

العربية English

Search live market data

Home Briefing Developers Pricing

جارٍ التحميل

Market intelligence API for developers and digital products.

Start free

Product

Home Briefing Pricing

Resources

API docs llms.txt Console

Company

Developers Log in Contact

Legal

Privacy Terms

Privacy Terms Contact Log in

جارٍ التحميل

Home Briefing Developers Pricing

Search live market data

العربية English

Search live market data

Home Briefing Developers Pricing

جارٍ التحميل

جارٍ التحميل

Market intelligence API for developers and digital products.

Start free

Product

Home Briefing Pricing

Resources

API docs llms.txt Console

Company

Developers Log in Contact

Legal

Privacy Terms

Privacy Terms Contact Log in

جارٍ التحميل

Hy-Tech Engineers vs Symbiotec Pharmalab vs Skyways Air | Market Intelligence API | Briefly NewsStream

Back to briefing

IndiaFinancial marketsAug 31, 2026, 6:38 AM

Hy-Tech Engineers vs Symbiotec Pharmalab vs Skyways Air IPO: Which Will List At Higher Premium?

Hy-Tech Engineers IPO leads listing day gains with an 81% upside, ahead of Skyways Air Services (28.6%) and Symbiotec Pharmalab (24.3%), per latest GMP.

Arabic

اكتتابات "هاي تك إنجينيرز" ضد "سيمبيوتيك فارمالاب" ضد "سكاي ويز إير": أيهم سيسجل علاوة إدراج أعلى؟

يتصدر اكتتاب "هاي تك إنجينيرز" مكاسب يوم الإدراج بإمكانية ارتفاع بنسبة 81%، متقدمًا على "سكاي ويز إير سيرفيسز" (28.6%) و"سيمبيوتيك فارمالاب" (24.3%)، وفقًا لأحدث أرقام علاوة السوق الرمادية (GMP).

English

Hy-Tech Engineers vs Symbiotec Pharmalab vs Skyways Air IPO: Which Will List At Higher Premium?

Hy-Tech Engineers IPO leads listing day gains with an 81% upside, ahead of Skyways Air Services (28.6%) and Symbiotec Pharmalab (24.3%), per latest GMP.

Read original source Today's stories